MedPath

Mindfulness-based Cognitive Therapy for Chronic Depression

Phase 2
Completed
Conditions
Chronic Major Depression
Registration Number
NCT01065311
Lead Sponsor
Johannes Michalak
Brief Summary

The propose of the study is to investigate the efficacy of Mindfulness-based Cognitive Therapy (MBCT, Segal, Williams, \& Teasdale, 2002) for patients suffering from Chronic Major Depression. The efficacy of MBCT will be compared with the Cognitive Behavioral Analysis System of Psychotherapy (McCullough, 2003), a treatment approach, which has proven it's efficacy yet, and with a treatment-as-usual condition (standard psychiatric outpatient care).

Detailed Description

Cognitive Behavioral Analysis System of Psychotherapy (CBASP) is a treatment approach specifically developed for the treatment of chronic depression. CBASP aims to change dysfunctional interpersonal patterns. Mindfulness-based Cognitive Therapy (MBCT) has recently been proposed as a further treatment option for chronic depression. MBCT trains patients to step out of negative ruminative states of mind. There are no direct comparisons of the psychological treatment options for chronic depression.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
106
Inclusion Criteria
  • Clinical diagnoses of Major Depression, single episode, chronic or
  • Major Depression, recurrent, chronic
  • Hamilton Rating Scale for Depression score > 14
  • Beck Depression Inventory II score > 14
Exclusion Criteria
  • History of Schizophrenia or Schizoaffective Disorder
  • Current Substance Dependence or Eating Disorder
  • Mental Disorder Due to General Medical Condition
  • Borderline Personality Disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Hamilton Rating Scale for DepressionChange from Baseline in HAM-D at 8 weeks
Secondary Outcome Measures
NameTimeMethod
Beck Depression Inventory IIChange from Baseline in BDI-II at 6 months
Social Adaption Self-evaluation ScaleChange from Baseline in SASS at 6 months
Short Form (36) Health SurveyChange from Baseline in SF-36 at 6 months
Global Assessment of Functioning ScaleChange from Baseline in GAF at 6 months
Response Styles QuestionnaireChange from Baseline in RSQ at 6 months

Trial Locations

Locations (1)

University of Hildesheim

🇩🇪

Hildesheim, Germany

University of Hildesheim
🇩🇪Hildesheim, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.